BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies
12 September 2024 | News
Suzhou, China – BIOCHINA2024, a premier event in the biotechnology and pharmaceutical industries, successfully concluded with a record-breaking 27,931 registrants, 480 exhibitors, and 839 speakers from around the world. This year's event, held in Suzhou, highlighted cutting-edge advancements in drug licensing, supply chain optimization, product promotion, and funding access within the biotech sector.
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition of the event covering 50,000 square meters across five halls. Exhibitors will showcase a wide range of products and services, including pharmaceutical equipment, laboratory instruments, technical services, and raw materials, as well as reagents and consumables. International exhibitors will also be a key highlight.
BIOCHINA 2025 will associate with top-tier Chinese biotech and biopharmaceutical companies, covering key areas such as cell and gene therapy, antibody drugs, vaccines, small molecule drugs, peptide drugs, and nucleic acid drugs. This focus on advanced biotechnologies positions BIOCHINA 2025 as a central hub for innovation and collaboration in the industry.
Bio-Partnering at BIOCHINA 2025
As China’s largest bio convention organizer, BIOCHINA provides a robust platform for business meetings and networking opportunities through its BiO Partnering system. This system brings together biotech and biopharmaceutical founders, investors, and business development leaders. Each session offers 30-minute one-on-one meetings designed to foster collaborations and drive industry growth.
For More Information:
Visit the official BIOCHINA website: BIOCHINA (biocn.cn)
Exhibiting and Registering Contact: Jessie Yu, jessieyu@enmore.com
Registration:
Register for BIOCHINA 2025: BIOCHINA 2025 Registration (bagevent.com)
